Company-wide revenue
Reported revenue in 2020 ¥278.95B Reported revenue in 2024 ¥360.51B
- growth amount
- +¥81.56B
- growth annualized
- +6.6%
- growth total
- +29.2%
Japanese company profile · 3341
NIHON CHOUZAI CO.,LTD.
In its FY2024 public filing, NIHON CHOUZAI CO.,LTD. reports Pharmacy, Pharmaceutical Manufacturing and Sales Business, Healthcare staff sending and referral services. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 日本調剤株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
NIHON CHOUZAI CO.,LTD.'s largest reported business by revenue in FY2024 was Pharmacy.
The business with the highest reported segment profit in FY2024 was Pharmacy.
FY2024 · fiscal year ended March 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Pharmacy | ¥321.95B ↗ | 89.3% | ¥13.45B ↗ |
| Pharmaceutical Manufacturing and Sales Business | ¥40.16B ↗ | 11.1% | −¥630M ↗ |
| Healthcare staff sending and referral services | ¥11.37B ↗ | 3.2% | ¥937M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended March 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Pharmaceutical Manufacturing and Sales Business
- 医薬品製造販売事業
- Healthcare staff sending and referral services
- 医療従事者派遣・紹介事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Pharmaceutical Manufacturing and Sales Business
- 医薬品製造販売事業
- Healthcare staff sending and referral services
- 医療従事者派遣・紹介事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Pharmacy | ¥244.07B | ¥265.62B | ¥280.16B | ¥302.81B | ¥321.95B |
| Pharmaceutical Manufacturing and Sales Business | ¥45.7B | ¥44.84B | ¥38.58B | ¥40.45B | ¥40.16B |
| Healthcare staff sending and referral services | ¥8.39B | ¥6.99B | ¥8.06B | ¥9.98B | ¥11.37B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Pharmacy
Reported revenue in 2020 ¥244.07B Reported revenue in 2024 ¥321.95B
- growth amount
- +¥77.88B
- growth annualized
- +7.2%
- growth total
- +31.9%
View original filing
Healthcare staff sending and referral services
Reported revenue in 2021 ¥6.99B Reported revenue in 2024 ¥11.37B
- growth amount
- +¥4.37B
- growth total
- +62.6%
View original filing
Reported revenue in 2020 ¥8.39B Reported revenue in 2024 ¥11.37B
- growth annualized
- +7.9%
- growth total
- +35.4%
View original filing
Healthcare staff sending and referral services
Reported profit margin in 2021 +8.2%
Reported profit margin in 2024 +8.2%
- growth margin points
- +0.0
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended March 2025
The source document may be in Japanese.
Filing ID: S100W6B8
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.